16th Dec 2008 14:12
RNS Number : 2269K
AGI Therapeutics plc
16 December 2008
AGI Therapeutics plc ("AGI" or the "Company")
Directors' Dealing
The Company was informed on 16 December 2008 of the following dealings by directors that were undertaken on 12 and 15 December 2008:
|
Shares Acquired |
Share Price |
Resulting Holding |
% of Enlarged Share Capital |
|
|
John Devane |
170,000 |
€0.18 |
10,255,576 |
15.2% |
|
David Kelly |
105,000 |
85,000 @ €0.18 20,000 @ €0.24 |
105,000 |
- |
|
Mary Martin |
17,000 |
€0.18 |
1,130,489 |
1.7% |
Contact Information:
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai